1. RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA
   C. James Block et al, 2021, Oncogene CrossRef
2. Role of RBMS3 Novel Potential Regulator of the EMT Phenomenon in Physiological and Pathological Processes
   Tomasz Górnicki et al, 2022, International Journal of Molecular Sciences CrossRef
3. RBMS3-induced circHECTD1 encoded a novel protein to suppress the vasculogenic mimicry formation in glioblastoma multiforme
   Xuelei Ruan et al, 2023, Cell Death & Disease CrossRef
4. Identifying Critical States of Complex Diseases by Single-Sample Jensen-Shannon Divergence
   Jinling Yan et al, 2021, Frontiers in Oncology CrossRef
5. Expression of RBMS3 in Breast Cancer Progression
   Tomasz Górnicki et al, 2023, International Journal of Molecular Sciences CrossRef
6. Tumor suppressor function of RBMS3 overexpression in EOC associated with immune cell infiltration
   Tian Yin et al, 2024, Heliyon CrossRef
7. Serum exosomal miR‐3662 down‐regulates the expression of RBMS3 to promote malignant progression and gemcitabine resistance of breast cancer cells
   Xiang Li et al, 2024, Chemical Biology & Drug Design CrossRef
8. RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities
   Shimeng Wang et al, 2024, Critical Reviews in Oncology/Hematology CrossRef